Worth Venture Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Worth Venture Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,824	Closed	-$398K	–	133
2020 Q4	$398K	Sell	2,824 -2,297	-45%	-$294K	0.32%	65
2020 Q3	$571K	Buy	5,121 +206	+4%	+$23.1K	0.47%	53
2020 Q2	$550K	Sell	4,915 -2,129	-30%	-$210K	0.27%	61
2020 Q1	$545K	Buy	7,044 +972	+16%	+$86.1K	0.34%	44
2019 Q4	$578K	Buy	6,072 +187	+3%	+$16.2K	0.28%	46
2019 Q3	$449K	Sell	5,885 -3,306	-36%	-$275K	0.26%	47
2019 Q2	$806K	Buy	9,191 +1,398	+18%	+$119K	0.45%	31
2019 Q1	$705K	Sell	7,793 -201	-3%	-$17.1K	0.39%	33
2018 Q4	$573K	Buy	7,994 +2,178	+37%	+$175K	0.43%	39
2018 Q3	$558K	Sell	5,816 -89	-2%	-$8.63K	0.42%	35
2018 Q2	$562K	Sell	5,905 -1,313	-18%	-$121K	0.46%	31
2018 Q1	$633K	Sell	7,218 -134	-2%	-$12.2K	0.55%	39
2017 Q4	$624K	Sell	7,352 -966	-12%	-$80.9K	0.69%	40
2017 Q3	$720K	Sell	8,318 -2,916	-26%	-$234K	0.62%	33
2017 Q2	$867K	Sell	11,234 -2,058	-15%	-$146K	0.75%	27
2017 Q1	$922K	Buy	+13,292	New	+$893K	0.81%	23

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Worth Venture Partners's XBI Position: Q1 2021 in Review

Worth Venture Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2021, closing a stake of 2,824 shares — an estimated $398K sold.

Worth Venture Partners first reported a position in XBI in Q1 2017 and held it in 16 quarters. The position peaked at $922K in Q1 2017. 643 funds tracked by Wall St. Rank hold XBI as of Q1 2021.

Worth Venture Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2021 after selling out during the quarter.
Worth Venture Partners sold 2,824 State Street SPDR S&P Biotech ETF shares in Q1 2021, an estimated $398K.
Worth Venture Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 16 quarters.
Worth Venture Partners's State Street SPDR S&P Biotech ETF position peaked at $922K in Q1 2017.
643 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2021.

Based on Worth Venture Partners's 13F filing for Q1 2021, filed 17 May 2021.